{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:19:58Z","timestamp":1781284798464,"version":"3.54.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Age-related Macular degeneration (AMD) is a major cause of vision loss and is linked to several predisposing single nucleotide polymorphisms (SNPs). CRISPR-mediated genome editing offers the potential to target negatively associated SNPs in an allele-specific manner, necessitating the need for a relevant cell model. The ARPE-19 cell line, with its stable monolayer growth and retinal pigment epithelium (RPE) characteristics, serves as an ideal model for AMD studies. Chronic inflammation and complement system dysregulation are implicated in AMD pathogenesis. Most genetic variations associated with AMD are in complement genes, suggesting their regulatory role. In this study, we conducted targeted PCRs to identify AMD-related SNPs in ARPE-19 cells and used CRISPR constructs to assess allele-specific activity. Guide RNA sequences were cloned into an EF-1-driven SpCas9 vector and packaged into lentivirus. Targeting efficiencies were evaluated with TIDE analysis, and allele-specificity was measured with NGS analysis 30 days post-transduction. Our results showed varying targeting efficiencies depending on guide RNA efficacy. For example, TIDE analysis of CFH SNPs rs1061170 and rs1410996 revealed efficiencies of 35.5% and 33.8%, respectively. CFB SNP rs4541862 showed efficiencies from 3% to 36.7%, and rs641153 ranged from 3.4% to 23.8%. Additionally, allele-specific targeting of AMD-related SNPs rs1061170, rs1410996, rs4541862, and rs641153 ranged from 48% to 52% in heterozygous differentiated ARPE-19 cells. These findings demonstrate the potential to manipulate the complement system in an AMD model by targeting disease-associated SNPs in an allele-specific manner, offering a promising therapeutic approach.<\/jats:p>","DOI":"10.1038\/s41434-025-00522-z","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T12:04:30Z","timestamp":1742299470000},"page":"132-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CRISPR targeting of SNPs associated with age-related macular degeneration in ARPE-19 cells: a potential model for manipulating the complement system"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4300-2033","authenticated-orcid":false,"given":"Ahmed","family":"Salman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Kyung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2941-4464","authenticated-orcid":false,"given":"Michelle E.","family":"McClements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"MacLaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"522_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bjophthalmol-2013-304033","volume":"98","author":"RR Bourne","year":"2014","unstructured":"Bourne RR, Jonas JB, Flaxman SR, Keeffe J, Leasher J, Naidoo K, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. Br J Ophthalmol. 2014;98:629\u201338.","journal-title":"Br J Ophthalmol"},{"key":"522_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106\u201316.","journal-title":"Lancet Glob Health"},{"key":"522_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-0","volume":"134","author":"DH Anderson","year":"2002","unstructured":"Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411\u201331.","journal-title":"Am J Ophthalmol"},{"key":"522_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1109557","volume":"308","author":"RJ Klein","year":"2005","unstructured":"Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385\u20139.","journal-title":"Science"},{"key":"522_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1126\/science.1110189","volume":"308","author":"AO Edwards","year":"2005","unstructured":"Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421\u20134.","journal-title":"Science"},{"key":"522_CR6","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1097\/IAE.0b013e318184661d","volume":"28","author":"JM Lin","year":"2008","unstructured":"Lin JM, Tsai YY, Wan L, Lin HJ, Tsai Y, Lee CC, et al. Complement factor H variant increases the risk for early age-related macular degeneration. Retina. 2008;28:1416\u201320.","journal-title":"Retina"},{"key":"522_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.eye.6702176","volume":"20","author":"S Sivaprasad","year":"2006","unstructured":"Sivaprasad S, Chong NV. The complement system and age-related macular degeneration. Eye. 2006;20:867\u201372.","journal-title":"Eye"},{"key":"522_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/5056","volume":"21","author":"XR Jiang","year":"1999","unstructured":"Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet. 1999;21:111\u20134.","journal-title":"Nat Genet"},{"key":"522_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.279.5349.349","volume":"279","author":"AG Bodnar","year":"1998","unstructured":"Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349\u201352.","journal-title":"Science"},{"key":"522_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1242\/jcs.104.1.37","volume":"104","author":"IR Nabi","year":"1993","unstructured":"Nabi IR, Mathews AP, Cohen-Gould L, Gundersen D, Rodriguez-Boulan E. Immortalization of polarized rat retinal pigment epithelium. J Cell Sci. 1993;104:37\u201349.","journal-title":"J Cell Sci"},{"key":"522_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/exer.1996.0020","volume":"62","author":"KC Dunn","year":"1996","unstructured":"Dunn KC, AotakiKeen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62:155\u201369.","journal-title":"Exp Eye Res"},{"key":"522_CR12","first-page":"60","volume":"23","author":"W Samuel","year":"2017","unstructured":"Samuel W, Jaworski C, Postnikova OA, Kutty RK, Duncan T, Tan LX, et al. Appropriately differentiated ARPE-19 cells regain phenotype and gene expression profiles similar to those of native RPE cells. Mol Vis. 2017;23:60\u201389.","journal-title":"Mol Vis"},{"key":"522_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/JLB.3MIR0220-270R","volume":"108","author":"MW Lo","year":"2020","unstructured":"Lo MW, Woodruff TM. Complement: Bridging the innate and adaptive immune systems in sterile inflammation. J Leukoc Biol. 2020;108:339\u201351.","journal-title":"J Leukoc Biol"},{"key":"522_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT. Complement System Part II: Role in Immunity. Front Immunol. 2015;6:257.","journal-title":"Front Immunol"},{"key":"522_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"M Noris","year":"2013","unstructured":"Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33:479\u201392.","journal-title":"Semin Nephrol"},{"key":"522_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1471-4906(03)00030-9","volume":"24","author":"AJ Nauta","year":"2003","unstructured":"Nauta AJ, Daha MR, van Kooten C, Roos A. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol. 2003;24:148\u201354.","journal-title":"Trends Immunol"},{"key":"522_CR17","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344:1058\u201366.","journal-title":"N Engl J Med"},{"key":"522_CR18","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","volume":"190","author":"D Ricklin","year":"2013","unstructured":"Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol. 2013;190:3831\u20138.","journal-title":"J Immunol"},{"key":"522_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100952","volume":"84","author":"S de Jong","year":"2021","unstructured":"de Jong S, Gagliardi G, Garanto A, de Breuk A, Lechanteur YTE, Katti S, et al. Implications of genetic variation in the complement system in age-related macular degeneration. Prog Retin Eye Res. 2021;84:100952.","journal-title":"Prog Retin Eye Res"},{"key":"522_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","volume":"33","author":"I Bhutto","year":"2012","unstructured":"Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): Relationships between the photoreceptor\/retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex. Mol Aspects Med. 2012;33:295\u2013317.","journal-title":"Mol Aspects Med"},{"key":"522_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.preteyeres.2018.04.006","volume":"67","author":"EM van Leeuwen","year":"2018","unstructured":"van Leeuwen EM, Emri E, Merle BMJ, Colijn JM, Kersten E, Cougnard-Gregoire A, et al. A new perspective on lipid research in age-related macular degeneration. Prog Retin Eye Res. 2018;67:56\u201386.","journal-title":"Prog Retin Eye Res"},{"key":"522_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.1110359","volume":"308","author":"JL Haines","year":"2005","unstructured":"Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419\u201321.","journal-title":"Science"},{"key":"522_CR23","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1073\/pnas.0501536102","volume":"102","author":"GS Hageman","year":"2005","unstructured":"Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"522_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48:134\u201343.","journal-title":"Nat Genet"},{"key":"522_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ng.2578","volume":"45","author":"LG Fritsche","year":"2013","unstructured":"Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, et al. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45:433\u20139.","journal-title":"Nat Genet"},{"key":"522_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng1750","volume":"38","author":"B Gold","year":"2006","unstructured":"Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet. 2006;38:458\u201362.","journal-title":"Nat Genet"},{"key":"522_CR27","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/ng2131","volume":"39","author":"JB Maller","year":"2007","unstructured":"Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet. 2007;39:1200\u20131.","journal-title":"Nat Genet"},{"key":"522_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ejhg.2008.140","volume":"17","author":"JA Fagerness","year":"2009","unstructured":"Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet. 2009;17:100\u20134.","journal-title":"Eur J Hum Genet"},{"key":"522_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1056\/NEJMoa072618","volume":"357","author":"JRW Yates","year":"2007","unstructured":"Yates JRW, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, et al. Complement C3 variant and the risk of age-related macular degeneration. New Engl J Med. 2007;357:553\u201361.","journal-title":"New Engl J Med"},{"key":"522_CR30","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ng1890","volume":"38","author":"AE Hughes","year":"2006","unstructured":"Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet. 2006;38:1173\u20137.","journal-title":"Nat Genet"},{"key":"522_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.eye.6701978","volume":"19","author":"J Thornton","year":"2005","unstructured":"Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye. 2005;19:935\u201344.","journal-title":"Eye"},{"key":"522_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346:1258096.","journal-title":"Science"},{"key":"522_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.pmbts.2021.01.024","volume":"182","author":"A Kantor","year":"2021","unstructured":"Kantor A, McClements ME, Peddle CF, Fry LE, Salman A, Cehajic-Kapetanovic J, et al. CRISPR genome engineering for retinal diseases. Prog Mol Biol Transl Sci. 2021;182:29\u201379.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"522_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/BST20190119","volume":"48","author":"C Hidalgo-Cantabrana","year":"2020","unstructured":"Hidalgo-Cantabrana C, Barrangou R. Characterization and applications of Type I CRISPR-Cas systems. Biochem Soc Trans. 2020;48:15\u201323.","journal-title":"Biochem Soc Trans"},{"key":"522_CR35","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science. 2012;337:816\u201321.","journal-title":"Science"},{"key":"522_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nbt.2842","volume":"32","author":"JD Sander","year":"2014","unstructured":"Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol. 2014;32:347\u201355.","journal-title":"Nat Biotechnol"},{"key":"522_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1021\/acschembio.7b00760","volume":"13","author":"DN Gallagher","year":"2018","unstructured":"Gallagher DN, Haber JE. Repair of a Site-Specific DNA Cleavage: Old-School Lessons for Cas9-Mediated Gene Editing. ACS Chem Biol. 2018;13:397\u2013405.","journal-title":"ACS Chem Biol"},{"key":"522_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.molimm.2016.11.016","volume":"84","author":"MJ Geerlings","year":"2017","unstructured":"Geerlings MJ, de Jong EK, den Hollander AI. The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment. Mol Immunol. 2017;84:65\u201376.","journal-title":"Mol Immunol"},{"key":"522_CR39","doi-asserted-by":"crossref","unstructured":"Salman A, McClements ME, MacLaren RE. CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications\/Avenues. Int J Mol Sci. 2024;25:1697.","DOI":"10.3390\/ijms25031697"},{"key":"522_CR40","doi-asserted-by":"publisher","first-page":"e0129945","DOI":"10.1371\/journal.pone.0129945","volume":"10","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Huang Q, Tang M, Zhang J, Fan W. Complement Factor H Expressed by Retinal Pigment Epithelium Cells Can Suppress Neovascularization of Human Umbilical Vein Endothelial Cells: An in vitro Study. PLoS One. 2015;10:e0129945.","journal-title":"PLoS One"},{"key":"522_CR41","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1089\/crispr.2019.0006","volume":"2","author":"E Rayner","year":"2019","unstructured":"Rayner E, Durin MA, Thomas R, Moralli D, O\u2019Cathail SM, Tomlinson I, et al. CRISPR-Cas9 Causes Chromosomal Instability and Rearrangements in Cancer Cell Lines, Detectable by Cytogenetic Methods. CRISPR J. 2019;2:406\u201316.","journal-title":"CRISPR J"},{"key":"522_CR42","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman EK, Chen T, Amendola M, van Steensel B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 2014;42:e168.","journal-title":"Nucleic Acids Res"},{"key":"522_CR43","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement K, Rees H, Canver MC, Gehrke JM, Farouni R, Hsu JY, et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat Biotechnol. 2019;37:224\u20136.","journal-title":"Nat Biotechnol"},{"key":"522_CR44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-1-4939-7680-5_17","volume":"1745","author":"E Fasler-Kan","year":"2018","unstructured":"Fasler-Kan E, Aliu N, Wunderlich K, Ketterer S, Ruggiero S, Berger S, et al. The Retinal Pigment Epithelial Cell Line (ARPE-19) Displays Mosaic Structural Chromosomal Aberrations. Methods Mol Biol. 2018;1745:305\u201314.","journal-title":"Methods Mol Biol"},{"key":"522_CR45","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.molcel.2015.04.028","volume":"58","author":"M Boettcher","year":"2015","unstructured":"Boettcher M, McManus MT. Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR. Mol Cell. 2015;58:575\u201385.","journal-title":"Mol Cell"},{"key":"522_CR46","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","volume":"46","author":"F Jiang","year":"2017","unstructured":"Jiang F, Doudna JA. CRISPR-Cas9 Structures and Mechanisms. Annu Rev Biophys. 2017;46:505\u201329.","journal-title":"Annu Rev Biophys"},{"key":"522_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339:823\u20136.","journal-title":"Science"},{"key":"522_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ibmb.2017.08.009","volume":"89","author":"Y Huang","year":"2017","unstructured":"Huang Y, Wang Y, Zeng B, Liu Z, Xu X, Meng Q, et al. Functional characterization of Pol III U6 promoters for gene knockdown and knockout in Plutella xylostella. Insect Biochem Mol Biol. 2017;89:71\u20138.","journal-title":"Insect Biochem Mol Biol"},{"key":"522_CR49","doi-asserted-by":"crossref","unstructured":"Belhaj K, Chaparro-Garcia A, Kamoun S, Nekrasov V. Plant genome editing made easy: targeted mutagenesis in model and crop plants using the CRISPR\/Cas system. Plant Methods. 2013;9:39.","DOI":"10.1186\/1746-4811-9-39"},{"key":"522_CR50","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.7150\/thno.43298","volume":"10","author":"J Wu","year":"2020","unstructured":"Wu J, Tang B, Tang Y. Allele-specific genome targeting in the development of precision medicine. Theranostics. 2020;10:3118\u201337.","journal-title":"Theranostics"},{"key":"522_CR51","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nbt.2508","volume":"31","author":"W Jiang","year":"2013","unstructured":"Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol. 2013;31:233\u20139.","journal-title":"Nat Biotechnol"},{"key":"522_CR52","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR\/Cas systems. Science. 2013;339:819\u201323.","journal-title":"Science"},{"key":"522_CR53","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nbt.2673","volume":"31","author":"V Pattanayak","year":"2013","unstructured":"Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol. 2013;31:839\u201343.","journal-title":"Nat Biotechnol"},{"key":"522_CR54","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nbt.2889","volume":"32","author":"X Wu","year":"2014","unstructured":"Wu X, Scott DA, Kriz AJ, Chiu AC, Hsu PD, Dadon DB, et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol. 2014;32:670\u20136.","journal-title":"Nat Biotechnol"},{"key":"522_CR55","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/gkv137","volume":"43","author":"H O\u2019Geen","year":"2015","unstructured":"O\u2019Geen H, Henry IM, Bhakta MS, Meckler JF, Segal DJ. A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture. Nucleic Acids Res. 2015;43:3389\u2013404.","journal-title":"Nucleic Acids Res"},{"key":"522_CR56","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013;31:827\u201332.","journal-title":"Nat Biotechnol"},{"key":"522_CR57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34:184\u201391.","journal-title":"Nat Biotechnol"},{"key":"522_CR58","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ymthe.2020.11.009","volume":"29","author":"R Rabinowitz","year":"2021","unstructured":"Rabinowitz R, Offen D. Single-Base Resolution: Increasing the Specificity of the CRISPR-Cas System in Gene Editing. Mol Ther. 2021;29:937\u201348.","journal-title":"Mol Ther"},{"key":"522_CR59","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","volume":"74","author":"F Sanger","year":"1977","unstructured":"Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 1977;74:5463\u20137.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00522-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T03:24:44Z","timestamp":1743305084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00522-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1038\/s41434-025-00522-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4755651\/v1","asserted-by":"object"}]},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}